Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center by Ferreira, Flávia Regina et al.
An Bras Dermatol. 2014;89(5):745-50.
s
Epidemiological profile of nonmelanoma skin cancer in renal
transplant recipients: experience of a referral center*
Flávia Regina Ferreira1 Marilia Marufuji Ogawa2
Luiz Fernando Costa Nascimento1 Jane Tomimori2
DOI: http://dx.doi.org/10.1590/abd1806-4841.20142590
Abstract: BACKGROUND: Nonmelanoma skin cancer is the most common form of cancer in humans and also the
malignant disease that is increasingly common among kidney transplant recipients. 
OBJECTIVE: To determine the epidemiological characteristics of renal transplant recipients with nonmelanoma skin
cancer seen at a referral transplantation center. 
METHODS: Cross-sectional descriptive study with renal transplant recipients presenting nonmelanoma skin cancer,
treated at a transplantation referral center between 08/01/2004 and 08/31/2009. Analyzed variables were: gen-
der, age, skin phototype, occupational and recreational sun exposure, use of photoprotection, personal and fami-
ly history of non-melanoma skin cancer, clinical type and location, time between transplantation and the appear-
ance of the first nonmelanoma skin cancer, occurrence of viral warts, timing of transplantation, type of donor,
cause of kidney failure, previous transplants, comorbidities, pre-transplant dialysis, type and duration of dialysis.
RESULTS: 64 subjects were included. Males - 71.9%; low skin phototypes (up to Fitzpatrick III) - 89%; mean age -
57.0 years - and mean age at transplant - 47.3 years; sun exposure - 67.2% occupational - and 64.1% recreational;
photoprotection - 78.2% (although only 34.4% in a regular manner); squamous cell carcinoma - 67.2%; squamous
cell carcinoma/basal cell carcinoma ratio - 2:1; personal history of nonmelanoma skin cancer - 25% - and family
history - 10.9%; location at photoexposed area - 98.4%; average latency time between transplantation and first non-
melanoma skin cancer appearance - 78.3 months; viral warts (HPV) after transplant - 53.1%; average timing of
transplantation - 115.5 months; living donor - 64.1%; triple regimen (antirejection) - 73.2%; comorbidities - 92.2%;
pre-transplant dialysis - 98.4%; hemodialysis - 71.7%; average duration of dialysis - 39.1 months; previous trans-
plants - 3.1%; hypertension as cause of renal failure - 46.9%. 
CONCLUSION: This study allowed the epidemiological characterization of a population of kidney transplant recip-
ients with nonmelanoma skin cancer.
Keywords: Basal cell carcinoma; Squamous cell carcinoma; epidemiology; Basal cell neoplasms; Squamous cell
neoplasms; Skin cancer; transplants
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INTRODUCTION
Non-melanoma skin cancer (NMSC) is the most
common form of cancer among humans. At the end of
the last century, the study of this malignancy became
a constant concern among researchers due to an exac-
erbated increase in its incidence worldwide, with the
detection of high-risk groups remaining a priority for
any preventive action.1
In recent decades, there has also been a dramat-
ic increase in the number of patients iatrogenically
submitted to chronic immunosuppression. This is
largely due to antirejection regimens associated with
organ transplants.2
NMSC is the malignant disease that is most
rapidly growing among the group of renal transplant
recipients (RTRs).3,4 Several factors work together to
increase the risk of cutaneous cancer in these patients,
such as: sunlight exposure, individual genetic back-
ground, family history, race/skin phototype, age, use
of immunosuppressive drugs and viral infection.
São Paulo Hospital (HSP) along with the
Kidney and Hypertension Hospital (HRH) linked to
Federal University of São  Paulo - Paulista Medical
School (UNIFESP-EPM) constitute the largest health-
care unit in kidney transplant volume in Latin
America. Since January 2004, the department of der-
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matology at UNIFESP-EPM offers a specific clinic for
the follow-up of solid organ transplant recipients with
dermatoses, the vast majority being RTRs. 
Due to our population’s diversity, we must
establish in our region the epidemiological profile of
RTRs with NMSC. Thus, we organized the clinical
data recorded during the consultations of RTRs with
NMSC and performed a transversal study, collecting
information regarding these patients’ habits. 
MATERIALS AND METHODS
This is a cross-sectional descriptive study, con-
ducted at the solid organ transplant division of the
department of dermatology  at Unifesp-EPM, during the
period between August 1st 2004 and August 31st 2009. 
To be included in this study the patient had to
fulfill the following criteria: age over 18 years, resi-
dent of São Paulo State, RTR, no other organ trans-
plant; presence of nonmelanoma skin cancer after the
transplant, confirmed by anatomopathological exam;
current use of transplant immunosuppressive drugs;
having attended the department of dermatology at
Unifesp-EPM between August 2004 and August 2009.
Individuals that failed to fulfill all of the aforemen-
tioned criteria were excluded from the study. 
Patients answered a questionnaire applied by
the authors and had their skin and mucosae examined
by a dermatologist. 
The following parameters were studied: 
Demographic characteristics: gender (male or
female), age (in years),  skin phototype (according to
Fitzpatrick classification), origin (São Paulo State –
capital or countryside);
Personal habits: occupational sun exposure (yes or
no), duration of occupational sun exposure (in years),
length (all day, parts of the day) and number of hours
of occupational sun exposure (per day), recreational
sun exposure (yes or no), duration of recreational sun
exposure (in years), length (all day, parts of the day)
and number of hours of recreational sun exposure
(per day), type of recreational sun exposure (daily or
sporadic), use of photoprotection (yes, regularly; yes,
irregularly; no) and length of photoprotection usage
(in months);
NMSC related issues: clinical type, first NMSC or
not, number of tumors (one or multiple) at the time of
the interview, topographical localization of tumors
(photoexposed area or not), personal history of NMSC
(yes or no), family history of NMSC (yes or no), laten-
cy between transplant and tumor appearance (in
months), presence of viral warts after transplant (yes
or no) and
Transplant related issues: duration of transplant
(in months), type of donor (living or deceased), cause
of chronic kidney failure, previous kidney transplants
(yes or no), comorbidities (yes or no), pre-transplanta-
tion dialysis, type of pre-transplantation dialysis
(hemodialysis, peritoneal dialysis, both), duration of
dialysis (in months).
The occurrence of a new tumor in a patient
already included in the study was not considered as a
new case.
Tables with mean values, standard deviation,
medians, minimum and maximum values and
interquartile intervals for continuous variables were
constructed. Tables with absolute values and percent-
ages for the categorical variables were also designed.
Computer software SPSS 17.0 was used.
The present study was approved by the
Unifesp-EPM Institutional Review Board under num-
ber 0948/10.
RESULTS
Five hundred and twenty four RTR individuals
were seen at solid organ transplant division of the
department of dermatology  at Unifesp-EPM  between
August 1st 2004 and August 31st 2009, having being
referred from HSP and HRH by their general practi-
tioners or nephrologists on account of dermatological
lesions or complaints. Seventy patients (13.4%) ful-
filled the inclusion criteria for this study, of which 64
(91.4%) agreed to participate in it.
The descriptive analysis of the sample’s demo-
graphical parameters showed that, of the 64 included
individuals, 46 (71.9%) were males and 18 (28.1%)
were females. Mean age in the sample was 57 years
old (standard deviation sd=9.2), coinciding with the
median, with minimum age being 34 and maximum
77 years. Mean age at the time of transplant was 47.3
years (sd=11.9) and median was 48 years, with mini-
mum age 18 and maximum 69 years.
The sample’s skin phototypes varied from I to
V according to Fitzpatrick classification. The predom-
inant phototype in the population was III (43.7%),
with 89% of individuals presenting skin phototypes
up to III in the Fitzpatrick scale.
Thirty-five individuals (54.7%) were from São
Paulo city (capital), and the remainder (45.3%) was
from other cities in the countryside of São Paulo State.
Category variables of the demographical
parameters, comprising personal habits and trans-
plant issues with their respective percentage values
are depicted on table 1.
The descriptive analysis of parameters regard-
ing personal habits showed that 43 individuals
(67.2%) reported occupational sun exposure, with
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duration of employment requiring such exposure
ranging from two to 53 years, mean 19.6 years (sd =
13.2) and median of 15.0 years. The length of occupa-
tional sun exposure that predominated in the sample
corresponded to the “all day” option, reported by 39
patients (90.7%). Regarding the amount of time (in
hours) of occupational sun exposure, 25 of 43 indivi-
duals (58.2 %) reported being exposed between eight
and 12 hours.
Forty-one patients (64.1%) reported recreation-
al sun exposure. Among them, 31 (75.7%) stated that
the exposure did not occur daily, but sporadically (on
weekends). The hours of recreational sun exposure
that predominated in the sample corresponded also to
the “all day” option, reported by 28 subjects (68.3%).
Considering the 41 individuals that reported recre-
ational sun exposure, 30 (73.2%) were exposed for
more than two hours. The duration of recreational sun
exposure (in years) ranged from one to 60 years, with
mean of 24.8 years (sd = 16.3) and median of 20 years.
Fifty patients (78.1%) in the sample reported the
use of sunscreen, but only 34.4% of them used it in a
regular, daily manner (at least twice a day). Twelve
individuals (18.7%) reported no use at all of sun-
screen, while two patients (3.1%) reported no sun
exposure. Of the 50 subjects using sunscreen, 46
(92.0%) did so for the last 60 months. 
Table 2 includes continuous variables related to
personal habits parameters, with respective standard
deviations, medians, minimum and maximum values  
and interquartile intervals, including occupational
and recreational sun exposure. 
In the descriptive analysis of skin cancer-relat-
ed parameters, the predominant NMSC clinical type
was squamous cell carcinoma (SCC), with 43 cases
(67.2%); followed by basal cell carcinoma (BCC), with
21 cases (32.8%). The SCC/BCC ratio was 2:1. We con-
sidered, for this analysis, NMSC detected in patients
during their consultation in this referral clinic. 
Of the 64 individuals in the sample, 16 (25%)
already had a personal history of NMSC, while 48
(75%) presented NMSC for the first time. 
At the time of the interview, 26 individuals
(40.6%) had multiple NMSC, with lesion sites correspon-
ding to photoexposed areas in 63 individuals (98.4%). 
The average latency time (in months) between
transplantation and the onset of the first NMSC was
78.3 months (sd = 60.3), with a median of 64.5 months,
minimum of seven months and maximum of 300
months. The analysis by clinical type showed that, the
average latency times between transplantation and
first SCC and BCC onsets were 72.9 (sd = 56.8) and
89.4 months (sd = 66.9), with median of 60.0 and 95.0
months, respectively. 
Regarding family history of skin cancer, 57 sub-
jects (89.1%) reported negative past history and seven
patients (10.9%) reported positive history. 
The presence of viral warts (human papillo-
mavirus - HPV) after transplantation was observed in
34 subjects (53.1%) in this study. The average latency
time between transplantation and the onset of viral
warts was 71.5 months (sd = 56.1), with a minimum
TABLE 1: Distribution of demographical parameters’ catego-
ry variables related to personal habits and transplant issues,







São Paulo (capital) 35 (54.7)










Time of sun exposure *             
All day 39 (90.7)




Time of recreational sun exposure*       
All day 28 (68.3)
Parts of the day 13 (31.7)




Yes, regularly     22 (34.4)
Yes, irregularly 28 (43.8)
No 12 (18.7)










Type of dialysis**         
Hemodialysis 45 (71.4)





* Considering only individuals that reported sun exposure.
** Considering only individuals that were submitted to pre-transplantation dialysis.
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time of six months and maximum period of 240 months. 
The descriptive analysis of transplant-related
parameters showed that the average time of trans-
plantation in this sample was 115.5 months (sd = 72.6),
with a minimum of 18 months and maximum time of
385 months. 
Living donors were the predominant donor
type in the sample, with 41 cases (64.1%). 
The cause of renal function loss was known for
53 patients (82.8%) in the sample and unidentified for
the other 11 subjects (17.2%). The main cause of chron-
ic renal failure was systemic hypertension, in 30 cases
(46.9%); followed by nephritis, in 10 cases (15.7%); and
polycystic renal disease, in four cases (6.3%). Diabetes
mellitus accounted for 4.7% of the cases. 
Therapeutic schemes used for post-transplant
immunosuppression were varied. All patients in this
study underwent treatments with two or three drugs.
The triple scheme was used in 47 cases (73.4%), and the
double scheme in 17 individuals (26.6%). Drugs used
for post-transplant immunosuppression in the 64 sub-
jects included in this study were: prednisone,
tacrolimus, cyclosporine, azathioprine, mycophenolate
mofetil, mycophenolate sodium, sirolimus, everolimus
and RAD (drug in research protocol). Prednisone was
the most used drug (61 subjects, 95.3%). 
Fifty-nine subjects (92.2%) presented comorbidities.
Of the 64 subjects included in this study, 63
(98.4%) underwent pre-transplant dialysis. Among
them, the predominant dialysis modality was
hemodialysis, with 71.4%; followed by the association
of hemodialysis/peritoneal dialysis in 22.2%.
Peritoneal dialysis alone corresponded to 6.4% of the
sample population. The mean duration of dialysis
before transplantation was 39.1 months (sd = 31.3),
with minimum time of eight months and maximum of
144 months. 
Two patients (3.1%) reported previous trans-
plant in this study.
DISCUSSION
Skin cancers are the most common malignancy
among RTRs, representing almost 50% of the tumors in
this population.3,4 The reason for the dramatic increase
in their incidence among these patients  is due to a
reduction of immunosurveillance against cancer
caused by immunosuppressive antirejection regimens,
coupled with ultraviolet radiation (UVR) exposure.5
NMSC are associated with significant morbidi-
ty and mortality in organ transplant recipients
(OTR).6,7 They directly affect the viability of the trans-
plant and the recipient, as well as the patient’s quality
of life, due to the need for alterations on immunosup-
pressive regimens and the associated risk of graft loss.
Moreover, they present a more aggressive clinical
course in this group than in the immunocompetent
population.6,8 In the present study, the overall inci-
dence of NMSC in 524 RTRs treated at the referral cen-
ter during the pre-determined period was 13.3%,
which was higher than those reported in other rele-
vant studies.4,5 The prevailing tropical climate in the
state of São Paulo and its geographic latitude likely
contribute in part to explaining this finding, as well as
the referral bias of RTRs with more evident cutaneous
lesions on clinical examinations performed by general
practitioners or nephrologists. 
This work was not aimed at analyzing the
prevalence of NMSC in the universe of HSP and HRH
renal transplant recipients, but only in the group of
patients who were referred from these institutions by
their general practitioners or nephrologists with der-
matological complaints or lesions to the solid organ
transplant division of the department of dermatology
at UNIFESP-EPM. Thus, we cannot extrapolate the
frequencies found in other studies. 
Regarding gender, our data were in agreement
with the literature, which even points the male gender
as a risk factor for the development of NMSC in
RTRs.4-8 The higher incidence of renal transplants in
males, greater UVR exposure and lower adherence to
photoprotection guidelines may justify this finding.9
Analyses of patients’ mean age at the moment of
tumor diagnosis were not found in the literature; stud-
ies reported only age at transplant, which would be
directly proportional to the risk of developing skin can-
cer in RTRs.4-8 The mean age at transplant found in this
study, around the fourth decade of life, is in consonance
with data from national and international reports.4,6,9,10
TABLE 2: Mean values and corresponding standard deviations (sd), medians, minimum and maximum values (minimum-maxi-
mum) and interquartile intervals (IIQ or IQ) of continuous variables related to personal habits. São Paulo, Brazil, 2004-2009
Variable Mean (sd) Median Minimum-maximum IIQ
Duration of occupational sun exposure (in years)* 19.6 (13.2) 15.0 2-53 10.0-30.0
Number of hours of occupational sun exposure (daily)* 7.6 (3.0) 8.0 2-12 5.0-10.0
Duration of recreational sun exposure (in years)* 24.8 (16.3) 20.0 1-60 10.0-36.5
Number of hours of recreational sun exposure (daily)* 5.5 (3.2) 5.0 1-12 2.0-8.0
Length of photoprotection (in months)** 35.8 (37.5) 24 0-204 7.5-51.0
* Considering only the individuals that reported sun exposure. ** Considering only the individuals that reported photoprotection.
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The risk of developing NMSC is higher in peo-
ple with fair skin, light hair and eyes, which have dif-
ficulties in tanning and a tendency to sunburn. These
characteristics coincide with the profile found in this
sample, in which 89% of the subjects had skin photo-
types up to III in Fitzpatrick scale, with 45.3% present-
ing skin phototypes II or I.11 Studies conducted in the
immunocompetent population in this same region
(São Paulo state) found Fitzpatrick skin phototypes II
or lower as a susceptibility factor for the development
of NMSC and also showed skin cancer occurrence
ratio among whites and nonwhites of 4:1.12-15 The inci-
dence of NMSC in RTRs with higher skin phototypes
(III / IV), as observed in this study, is found in the lit-
erature and can be supported by the interference of
antirejection immunosuppression regimens out-
weighing the individual genetic predisposition.7,13
The UVR present in sunlight is clearly the most
important physical environmental carcinogen for the
development of skin cancer.16 The cumulative UVR
exposure in pre-and post-transplantation years is
directly related to NMSC pathogenesis. UVR alone
has the ability to initiate, promote and induce the pro-
gression of skin cancers.5 Considering the information
above, this study’s findings, regarding personal habits
(occupational and recreational sun exposure and pho-
toprotection), also contributed to the high overall inci-
dence of NMSC detected in this sample. 
Regarding clinical type, SCC predominated in
this population, similarly to the findings of Zavos et
al., Ramsay et al. and Falsarella et al. and in contrast to
the findings of Fuente et al.4,6,7,9
The presence of multiple tumors of the same
strain or different strains at the moment of diagnosis,
observed in this study, had already been reported in
other relevant papers, and the predilection for photoex-
posed areas was a consensus in the medical literature.4-8
The average latency period between transplan-
tation and the onset of the first NMSC is variable in
the literature.6,10 Our findings, regarding the average
latency time according to NMSC clinical type, were
contrary to those found in the literature, which point
to a longer quiescence period for SCC.6,9 The mean
latency time of 72.9 months for SCC versus 89.4
months for BCC could be explained by the lower fre-
quency of the latter. 
Reports on family history of NMSC in RTRs
were not found in the literature. However, we empha-
size the low rates of family history (10.9%) among
these patients, demonstrating that immunosuppres-
sion is a determining factor for NMSC development. 
Studies have shown relevant interactions
between HPV and UVR, cytokines and host cell pro-
teins, including p53 and pro-apoptotic protein Bak,
from Bcl-2 family, contributing to malignant transfor-
mation in cutaneous keratinocytes and the appear-
ance of NMSC in immunocompetent and immuno-
suppressed populations.5,17 HPV presence was
observed in more than half of the individuals in this
study, which may be acting as a tumor promoter, thus
deserving further investigation in this population. 
Living donors were the predominant donor
type in this sample, in contrast with the findings of
Ramsay et al. and Kasiske et al, who found a predom-
inance of deceased donors: 82.4% and 76% respective-
ly.10,18 Transplantations performed with live donor
organs do not usually demand intense immunosup-
pression as those that use organs from deceased
donors; however, the organ origin did not seem to
have interfered in this analysis. 
The variability in treatment regimens found in
the present study was also reported in the literature.
The adopted schemes also consisted of two or three
medications, always a systemic steroid (prednisone)
associated with one or two drugs.6,9,10,19 Comparative
studies between double and triple antirejection regi-
mens demonstrated that the level of immunosuppres-
sion - rather than the use of a particular agent/drug –
gives the proportional risk of NMSC development.6
Thus, the triple scheme, predominant in our sample, is
associated with an increased risk for NMSC compared
to the double regimen, which may explain the higher
overall incidence of NMSC found in this referral center. 
The presence of comorbidities (92.2% in this
study) has not been evaluated in the researched liter-
ature. In general, most RTRs have comorbidities due
to the use of immunosuppressive drugs or secondary
to the conditions that caused renal function loss, such
as hypercholesterolemia, hypertension, diabetes mel-
litus and nephritis. 
The mean duration of pre-transplant dialysis in
the literature ranged from 1.4 years (data by Ramsay
et al.) to three years or more  (demonstrated by
Kasiske et al.), with the latter being more in line with
the findings in this study.9,10,18 The type of dialysis was
not reported by the authors. In general, RTRs receiv-
ing deceased donor organs are submitted to dialysis
before transplantation, with all the accompanying
complications arising from this procedure, such as
serological conversion to viral infections. Therefore,
individuals undergoing dialysis have higher inci-
dence of comorbidities. 
The cause of renal function loss is controversial
in the literature, but primary kidney diseases
(glomerular, interstitial, polycystic, vascular), diabetes
mellitus and hypertension are among the main causes
in all studies.6,9,18
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CONCLUSION
This study allowed us to describe the epidemi-
ological profile of RTRs with NMSC seen at the solid
organ transplant division of the department of derma-
tology at  UNIFESP-EPM, during the period of
August 1st 2004 to August 31st 2009; with findings
sometimes consistent, sometimes conflicting with
national and international literature. However, the
data presented in this study permitted the identifica-
tion of RTRs with higher risk of developing NMSC.
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